title: Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?
authors.affiliation: Genitourinary Unit, Medical Oncology Department, National Cancer Institute, Milan, Italy.
authors.forename: Alessia
authors.initials: A
authors.lastname: Mennitto
authors.affiliation: Genitourinary Unit, Medical Oncology Department, National Cancer Institute, Milan, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Grassi
authors.affiliation: Genitourinary Unit, Medical Oncology Department, National Cancer Institute, Milan, Italy.
authors.forename: Elena
authors.initials: E
authors.lastname: Verzoni
authors.affiliation: Genitourinary Unit, Medical Oncology Department, National Cancer Institute, Milan, Italy.
authors.forename: Raffaele
authors.initials: R
authors.lastname: Ratta
authors.affiliation: Genitourinary Unit, Medical Oncology Department, National Cancer Institute, Milan, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Procopio
mesh_terms: D014408:Biomarkers, Tumor; D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging* / Q000473:pathology; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D018579:Patient Selection; D049268:Positron-Emission Tomography; D011379:Prognosis; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity
chemical_list: D014408:Biomarkers, Tumor; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: 
  FDG PET
  ; diagnostic imaging; renal cell carcinoma